<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="cytoa24782" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10953338</article-id><article-id pub-id-type="pmcid-ver">PMC10953338.1</article-id><article-id pub-id-type="pmcaid">10953338</article-id><article-id pub-id-type="pmcaiid">10953338</article-id><article-id pub-id-type="pmid">37772977</article-id><article-id pub-id-type="doi">10.1002/cyto.a.24782</article-id><article-id pub-id-type="publisher-id">CYTOA24782</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP&#8208;096: A 24&#8208;color flow cytometry panel to identify and characterize <styled-content style="fixed-case" toggle="no">CD4</styled-content>+ and <styled-content style="fixed-case" toggle="no">CD8</styled-content>+ tissue&#8208;resident T cells in human skin, intestinal, and type <styled-content style="fixed-case" toggle="no">II</styled-content> mucosal tissue</article-title><alt-title alt-title-type="left-running-head">O'Neil et al.</alt-title></title-group><contrib-group><contrib id="cytoa24782-cr-0001" contrib-type="author"><name name-style="western"><surname>O'Neil</surname><given-names initials="TR">Thomas R.</given-names></name><xref rid="cytoa24782-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24782-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cytoa24782-cr-0002" contrib-type="author"><name name-style="western"><surname>Harman</surname><given-names initials="AN">Andrew N.</given-names></name><xref rid="cytoa24782-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24782-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cytoa24782-cr-0003" contrib-type="author"><name name-style="western"><surname>Cunningham</surname><given-names initials="AL">Anthony L.</given-names></name><xref rid="cytoa24782-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24782-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cytoa24782-cr-0004" contrib-type="author"><name name-style="western"><surname>Nasr</surname><given-names initials="N">Najla</given-names></name><xref rid="cytoa24782-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24782-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cytoa24782-cr-0005" contrib-type="author" corresp="yes"><name name-style="western"><surname>Bertram</surname><given-names initials="KM">Kirstie M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9508-7537</contrib-id><xref rid="cytoa24782-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cytoa24782-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>kirstie.bertram@sydney.edu.au</email></address></contrib></contrib-group><aff id="cytoa24782-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>Centre for Virus Research, The Westmead Institute for Medical Research</institution>
<city>Westmead</city>
<country country="AU">Australia</country>
</aff><aff id="cytoa24782-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">The Westmead Clinical School, Faculty of Medicine and Health</named-content>
<institution>The University of Sydney</institution>
<city>Sydney</city>
<country country="AU">Australia</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Kirstie Melissa Bertram, The Westmead Institute for Medical Research, PO Box 412, Westmead, NSW 2145, Australia.<break/>
Email: <email>kirstie.bertram@sydney.edu.au</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>9</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2023</year></pub-date><volume>103</volume><issue seq="60">11</issue><issue-id pub-id-type="pmc-issue-id">458263</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v103.11</issue-id><fpage>851</fpage><lpage>856</lpage><history><date date-type="rev-recd"><day>06</day><month>4</month><year>2023</year></date><date date-type="received"><day>03</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>21</day><month>03</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-21 11:25:13.757"><day>21</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-103-851.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-103-851.pdf"/><abstract><title>Abstract</title><p>There is a great need to understand human immune cells within tissue, where disease manifests and infection occurs. Tissue&#8208;resident memory T cells (TRMs) were discovered over a decade ago, there is a great need to understand their role in human disease. We developed a 24&#8208;color flow cytometry panel to comprehensively interrogate CD4<sup>+</sup> and CD8<sup>+</sup> TRMs isolated from human tissues. When interrogating cells within human tissue, enzymatic methods used to liberate cells from within the tissue can cause cleavage of cell surface markers needed to phenotype these cells. Here we carefully select antibody clones and evaluate the effect of enzymatic digestion on the expression of markers relevant to the identification of T cell residency, as well as markers relevant to the activation and immunoregulation status of these cells. We have designed this panel to be applicable across a range of human tissues including skin, intestine, and type II mucosae such as the vagina.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cytoa24782-kwd-0001">CD4+ T cells</kwd><kwd id="cytoa24782-kwd-0002">CD8+ T cells</kwd><kwd id="cytoa24782-kwd-0003">enzymatic digestion</kwd><kwd id="cytoa24782-kwd-0004">flow cytometry</kwd><kwd id="cytoa24782-kwd-0005">human tissue</kwd><kwd id="cytoa24782-kwd-0006">tissue&#8208;resident memory T cells</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Health and Medical Research Council
</institution><institution-id institution-id-type="doi">10.13039/501100000925</institution-id></institution-wrap></funding-source><award-id>APP1181482</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Neil and Norma Hill Foundation
</institution><institution-id institution-id-type="doi">10.13039/501100005662</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0003"><funding-source>Westmead Medical Research Foundation</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="6"/><word-count count="4234"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:20.03.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="cytoa24782-cit-9001"><string-name name-style="western"><surname>O'Neil</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Harman</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Cunningham</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Nasr</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Bertram</surname><given-names>KM</given-names></string-name>. <article-title>OMIP&#8208;096: A 24&#8208;color flow cytometry panel to identify and characterize <styled-content style="fixed-case" toggle="no">CD4</styled-content>+ and <styled-content style="fixed-case" toggle="no">CD8</styled-content>+ tissue&#8208;resident T cells in human skin, intestinal, and type <styled-content style="fixed-case" toggle="no">II</styled-content> mucosal tissue</article-title>. <source>Cytometry</source>. <year>2023</year>;<volume>103</volume>(<issue>11</issue>):<fpage>851</fpage>&#8211;<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.24782</pub-id><pub-id pub-id-type="pmid">37772977</pub-id><pub-id pub-id-type="pmcid">PMC10953338</pub-id></mixed-citation>
</p></notes></front><body id="cytoa24782-body-0001"><sec sec-type="background" id="cytoa24782-sec-0001"><label>1</label><title>BACKGROUND</title><p>Tissue&#8208;resident memory cells (TRMs) are an experienced first&#8208;line effector cell defense against reinfection [<xref rid="cytoa24782-bib-0001" ref-type="bibr">1</xref>, <xref rid="cytoa24782-bib-0002" ref-type="bibr">2</xref>, <xref rid="cytoa24782-bib-0003" ref-type="bibr">3</xref>]. In chronic HIV infected individuals, CD3<sup>+</sup>CD4<sup>+</sup> T cells are depleted in intestinal mucosa [<xref rid="cytoa24782-bib-0004" ref-type="bibr">4</xref>], and cervical CD4<sup>+</sup> TRMs are a preferentially infected cell target for human immunodeficiency virus (HIV) [<xref rid="cytoa24782-bib-0005" ref-type="bibr">5</xref>]. In herpes simplex virus infection, mucosal CD4<sup>+</sup> and CD8<sup>+</sup> TRMs have been proposed as key targets for vaccines. The ability to accurately identify subsets of T cells within tissues will provide a foundation for understanding the pathology of diseases and assist in the development of therapeutic strategies [<xref rid="cytoa24782-bib-0001" ref-type="bibr">1</xref>, <xref rid="cytoa24782-bib-0003" ref-type="bibr">3</xref>]. We have designed a 24&#8208;color surface phenotyping panel to comprehensively phenotype CD4<sup>+</sup> and CD8<sup>+</sup> T cell subsets residing in healthy human mucosal tissues. This panel may also be used on human skin or for comparison with diseased tissues. A challenge to phenotyping cells from tissues is the cleavage of surface markers caused by enzymes used to liberate cells from tissues. We designed this panel with considerations for the cleavage of surface proteins using enzyme&#8208;optimized dissociation methods, and we successfully phenotyped TRMs in human epidermis, dermis, and lamina propria (Table&#160;<xref rid="cytoa24782-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="cytoa24782-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Summary table for application of OMIP.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Purpose</td><td align="left" valign="top" rowspan="1" colspan="1">Characterization of human CD4+ and CD8+ tissue resident T cells isolated from mucosal tissues</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">human</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Collagenase digested human tissue: human skin, intestine, type II mucosa (e.g., vagina, cervix)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;reference</td><td align="left" valign="top" rowspan="1" colspan="1">OMIP&#8208;070, OMIP&#8208;082</td></tr></tbody></table></table-wrap><p>There are three types of tissue that make up the anorectal and genital tracts: skin, type I mucosa, and type II mucosa. Skin is made up of an outer epidermal layer, including a superficial impervious keratinized layer of dead cells (stratum corneum), and an underlying dermal layer separated by a basement membrane. Skin covers the outermost parts of the body. Type II mucosae, such as vagina and inner foreskin, have an epidermal layer and an underlying lamina propria, a structure similar to the dermis, and contains no or a minimal keratinized layer. Type II mucosa is often found between outer skin and type I mucosal surfaces. Type I mucosae, such as endo&#8208;cervix and colorectal tissues, have a single layer of columnar epithelium, with underlying lamina propria.</p><p>TRMs require enzymes to liberate them from tissues. For skin and type II mucosa, dispase breaks down the basement membrane between epidermal and dermal/lamina propria layers, allowing these layers to be independently studied. Collagenase is generally a blend of several enzymes that will break down collagen, freeing the cells from the tissue. Unfortunately, enzymatic digestion procedures are known for cleaving cell surface proteins on immune cells [<xref rid="cytoa24782-bib-0006" ref-type="bibr">6</xref>]. Some studies will rest their cells for a period of time to recover this protein expression [<xref rid="cytoa24782-bib-0007" ref-type="bibr">7</xref>], although this has been shown to not truly reflect the cells as they were in tissue [<xref rid="cytoa24782-bib-0008" ref-type="bibr">8</xref>]. This non&#8208;specific cleavage of markers requires a series of optimization steps prior to panel development to be confident that the cells that are acquired are similar to those (in situ) within the tissue. A significant novelty of this publication is the application of our optimization protocols that minimize the effects of enzymatic cleavage on surface proteins [<xref rid="cytoa24782-bib-0006" ref-type="bibr">6</xref>, <xref rid="cytoa24782-bib-0009" ref-type="bibr">9</xref>, <xref rid="cytoa24782-bib-0010" ref-type="bibr">10</xref>]. This is primarily performed through the identification of the affected markers, and testing multiple antibody clones and alternative enzymes (Figures&#160;<xref rid="cytoa24782-supitem-0001" ref-type="supplementary-material">S3</xref> and <xref rid="cytoa24782-supitem-0001" ref-type="supplementary-material">S4</xref>).</p><p>We aimed to identify both CD4<sup>+</sup> and CD8<sup>+</sup> TRMs (Figure&#160;<xref rid="cytoa24782-fig-0001" ref-type="fig">1</xref>). Markers associated with residency span homing (chemokine) receptors, those associated with cell maintenance in tissue, and those that differ from circulating and non&#8208;resident tissue cells [<xref rid="cytoa24782-bib-0011" ref-type="bibr">11</xref>]. The best characterized receptors are CD69 and CD103, which delineate three main populations: CD69<sup>&#8722;</sup>CD103<sup>&#8722;</sup> non&#8208;TRMs, and two CD69<sup>+</sup> TRM populations delineated by CD103 expression. Higher proportions of CD103<sup>+</sup> cells are found in CD8<sup>+</sup> TRMs, but it is expressed on both CD4<sup>+</sup> and CD8<sup>+</sup> T cells. CD103<sup>+</sup> TRMs have functional and migratory differences to the CD103<sup>&#8722;</sup> counterpart [<xref rid="cytoa24782-bib-0012" ref-type="bibr">12</xref>, <xref rid="cytoa24782-bib-0013" ref-type="bibr">13</xref>]. There can be large differences in expression of CD103 between tissues demonstrated in Figure&#160;<xref rid="cytoa24782-fig-0001" ref-type="fig">1</xref> (large bowel mucosae and labia dermis). A small cluster of CD69<sup>&#8722;</sup>CD103<sup>+</sup> cells has been described as a TRM re&#8208;entering circulation [<xref rid="cytoa24782-bib-0014" ref-type="bibr">14</xref>]. These cells exit through lymphatics, and so the lymph&#8208;homing marker CCR7 was included to identify these cells. Markers associated with T cell tissue homing (CCR5, CCR6 [<xref rid="cytoa24782-bib-0015" ref-type="bibr">15</xref>]) and residency (CD127 [<xref rid="cytoa24782-bib-0016" ref-type="bibr">16</xref>], PD1 [<xref rid="cytoa24782-bib-0011" ref-type="bibr">11</xref>]) were also included.</p><fig position="float" fig-type="FIGURE" id="cytoa24782-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Gating strategy to identify CD3+ TRM cells in human anogenital tissues. Cells isolated from healthy human large bowel were stained and acquired on the BD FACSymphony A5 instrument. Cells were gated on single cells (FSC&#8208;A/FSC&#8208;H), CD45<sup>+</sup> lymphocytes (CD45/CD3) and live cells (FVS UV440/FSC&#8208;H). HLA&#8208;DR is used to gate on CD3<sup>+</sup> T cells, to account for the bright HLA&#8208;DR<sup>+</sup> autofluorescent mononuclear phagocyte cells spreading into the CD3 channel. On CD3<sup>&#8722;</sup> cells, pDCs are identified using CD123 and HLA&#8208;DR. On CD3<sup>+</sup> T cells, an additional tight gate is drawn around the lymphocyte cluster (FSC&#8208;A/SSC&#8208;A) to remove any additional contaminating mononuclear phagocytes. CD4<sup>+</sup> T cells and CD8<sup>+</sup> T cells are gated separately, and TRM subsets are gated on using CD69 and CD103 (non&#8208;TRM: CD69<sup>&#8722;</sup>CD103<sup>&#8722;</sup>; CD103<sup>&#8722;</sup> TRM: CD69<sup>+</sup>CD103<sup>&#8722;</sup>; CD103<sup>+</sup> TRM: CD69<sup>+</sup>CD103<sup>+</sup>). Labia dermal cells are included to compare CD103<sup>+</sup> TRMs in different tissues. (B) Histograms of markers expressed by labia dermal TRM subsets, split into CD4<sup>+</sup> and CD8<sup>+</sup> subsets. (C, D) Alternative representative FACS plots of those markers are presented as a histogram (E, F) Other marker expressions are represented using a variety of tissues where expression is prominent. (E) Representative expressions of CD94 on CD3<sup>+</sup>CD8<sup>+</sup> cells and HLA&#8208;DQ on CD3<sup>+</sup> HLA&#8208;DR<sup>+</sup> T cells from labia. (F) Representative images of CCR6, CCR10, and CCR7 expression on CD3<sup>+</sup> T cells from the large bowel, CD38 expression on CD3<sup>+</sup> T cells from the vagina epidermis, and CD154 expression on CD3<sup>+</sup> T cells from the small bowel. Representative figures are color&#8208;coordinated: large bowel&#8201;=&#8201;white, labia dermis&#8201;=&#8201;grey, vagina epidermis&#8201;=&#8201;orange, small bowel&#8201;=&#8201;light&#8208;red. [Color figure can be viewed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wileyonlinelibrary.com" ext-link-type="uri">wileyonlinelibrary.com</ext-link>]</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="CYTO-103-851-g001.jpg"/></fig><p>In early studies, TRMs were thought to be at the late stage of differentiation based on surface expressions. Recent studies suggest that TRMs can recirculate (CD4<sup>+</sup> TRMs in humans [<xref rid="cytoa24782-bib-0014" ref-type="bibr">14</xref>]; CD8<sup>+</sup> TRMs in mice: [<xref rid="cytoa24782-bib-0017" ref-type="bibr">17</xref>]) and, further, that they can revert to a central memory phenotype [<xref rid="cytoa24782-bib-0017" ref-type="bibr">17</xref>]. We have therefore included conventional memory markers (CD27, CD28, CCR7) to capture the memory T cell phenotype. In both CD4<sup>+</sup> and CD8<sup>+</sup> T cells, CD27 is used to delineate early differentiation (na&#239;ve &gt; central memory &gt; transitional memory) from later subsets (effector &gt; terminally differentiated memory). In blood, expression of CCR7, a lymph&#8208;homing molecule, describes a TCM or na&#239;ve cell. CD28 is a co&#8208;stimulatory molecule, which is upregulated following antigen stimulation and is decreased during T cell exhaustion. Therefore, together, we can identify a na&#239;ve cell (CCR7<sup>+</sup>CD27<sup>+</sup>CD28<sup>lo</sup>), central memory (CCR7<sup>+</sup>CD27<sup>+</sup>CD28<sup>hi</sup>), transitional memory (CCR7<sup>&#8722;</sup>CD27<sup>+</sup>CD28<sup>hi</sup>), effector memory (CCR7<sup>&#8722;</sup>CD27<sup>&#8722;</sup>CD28<sup>hi</sup>) and a terminally differentiated memory cell (CCR7<sup>&#8722;</sup>CD27<sup>&#8722;</sup>CD28<sup>&#8722;</sup>) in both CD4<sup>+</sup> and CD8<sup>+</sup> T cells.</p><p>We have also included two markers associated with the regulatory function of T cells: CD39 and TIGIT. CD39 is an exhaustion marker on virus&#8208;specific CD8<sup>+</sup> T cells in chronic diseases [<xref rid="cytoa24782-bib-0018" ref-type="bibr">18</xref>] and can also disrupt the anti&#8208;inflammatory responses [<xref rid="cytoa24782-bib-0019" ref-type="bibr">19</xref>]. CD8<sup>+</sup>CD39<sup>high</sup> TRMs were recently associated with positive prognosis of breast cancer [<xref rid="cytoa24782-bib-0020" ref-type="bibr">20</xref>]. In another study, regulatory T cells that were CD39<sup>high</sup> remain more stable under inflammatory conditions, compared to CD39<sup>low</sup> Tregs which lose their FOXP3 expression [<xref rid="cytoa24782-bib-0021" ref-type="bibr">21</xref>]. TIGIT expression in CD4<sup>+</sup> T cells is associated with thymic regulatory T cells [<xref rid="cytoa24782-bib-0022" ref-type="bibr">22</xref>]. A recent study found a TIGIT<sup>+</sup>CD39<sup>+</sup> CD4<sup>+</sup> TRM subset enriched in mucosa in Crohn's disease [<xref rid="cytoa24782-bib-0023" ref-type="bibr">23</xref>].</p><p>On T cells, CD161 describes unique subsets in CD4<sup>+</sup> and CD8<sup>+</sup> T cells. In CD8<sup>+</sup> T cells, CD161 expression defines a cytotoxic cell, and may play a role in CD8<sup>+</sup> T cell homing to tissue [<xref rid="cytoa24782-bib-0024" ref-type="bibr">24</xref>]. In CD4<sup>+</sup> T cells, CD161, with CCR6 and CCR10 describe effector T cell subsets. Th17 and Th22 cells play an important role in tissue maintenance, have been implicated in HIV infection and transmission, and their dysregulation can affect the severity of autoimmune diseases. CD161 and CCR6 are identifying markers for Th17 cells, while CCR6<sup>&#8722;</sup>CCR10<sup>+</sup> identifies Th22 cells. We did not include markers for identifying other CD4+ T cell subsets as their definition within tissue remains unsubstantiated and are not the primary focus of the panel.</p><p>In CD8<sup>+</sup> T cells, CD94, a C&#8208;type lectin receptor thought to have a regulatory function [<xref rid="cytoa24782-bib-0025" ref-type="bibr">25</xref>], is found on tumor&#8208;infiltrating cells and has been found on a unique cluster of CD8<sup>+</sup> T cells in Crohn's affected bowel tissue [<xref rid="cytoa24782-bib-0023" ref-type="bibr">23</xref>, <xref rid="cytoa24782-bib-0026" ref-type="bibr">26</xref>], although a clear definition of its function on T cells remains largely elusive.</p><p>The study of T cell activation has applications across a range of disciplines, such as virology, autoimmune, transplant immunology, among others. We have included a range of activation markers to define early&#8208; and late&#8208;activation specifically chosen for tissue&#8208;derived cells. HLA&#8208;DR is a late&#8208;activation marker, often expressed at low levels on activated T cells compared to mononuclear phagocytes. Another late activation marker, HLA&#8208;DQ, was brought to our attention by its differential expression in single&#8208;cell RNA sequencing data (Figure&#160;<xref rid="cytoa24782-supitem-0001" ref-type="supplementary-material">S8</xref>; [<xref rid="cytoa24782-bib-0027" ref-type="bibr">27</xref>, <xref rid="cytoa24782-bib-0028" ref-type="bibr">28</xref>, <xref rid="cytoa24782-bib-0029" ref-type="bibr">29</xref>]). CD154 (CD40LG) binds CD40 on antigen presenting cells and is required for Th17 polarization [<xref rid="cytoa24782-bib-0030" ref-type="bibr">30</xref>]. It is an early activation marker that was differentially expressed in transcriptomic analysis and played a role in Crohn's disease [<xref rid="cytoa24782-bib-0023" ref-type="bibr">23</xref>]. CD38, an early activation marker, is involved in cell adhesion and signal transduction [<xref rid="cytoa24782-bib-0031" ref-type="bibr">31</xref>]. Due to donor&#8208;to&#8208;donor variability, low, mild, or high amounts of inflammation may markedly influence proportions and expressions of activated cells. We are able to show low expressions of CD154 (small bowel) and CD38 (vagina epidermis) owing to the likely inflamed status of those individual tissues (Figure&#160;<xref rid="cytoa24782-fig-0001" ref-type="fig">1</xref>). CD123 was also included to identify and measure the presence of plasmacytoid dendritic (pDC) cells, which accumulate in inflamed [<xref rid="cytoa24782-bib-0032" ref-type="bibr">32</xref>] or virally infected tissue [<xref rid="cytoa24782-bib-0033" ref-type="bibr">33</xref>]. All reagents are summarised in Table&#160;<xref rid="cytoa24782-tbl-0002" ref-type="table">2</xref>.</p><table-wrap position="float" id="cytoa24782-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Reagents used for OMIP.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Specificity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fluorochrome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">CD45</td><td align="left" valign="top" rowspan="1" colspan="1">BB790</td><td align="left" valign="top" rowspan="1" colspan="1">HI30</td><td align="left" valign="top" rowspan="1" colspan="1">Leukocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1">NovaFluor B610&#8208;70s</td><td align="left" valign="top" rowspan="1" colspan="1">UCHT1</td><td align="left" valign="top" rowspan="1" colspan="1">T lymphocyte</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Viability</td><td align="left" valign="top" rowspan="1" colspan="1">FVS UV440</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Viability</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HLA&#8208;DR</td><td align="left" valign="top" rowspan="1" colspan="1">BV605</td><td align="left" valign="top" rowspan="1" colspan="1">G46&#8208;6</td><td align="left" valign="top" rowspan="1" colspan="1">Gate out MNPs; Late Activation on T cell</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD123</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;CY5</td><td align="left" valign="top" rowspan="1" colspan="1">6H6</td><td align="left" valign="top" rowspan="1" colspan="1">Plasmacytoid Dendritic Cell</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD4</td><td align="left" valign="top" rowspan="1" colspan="1">BUV805</td><td align="left" valign="top" rowspan="1" colspan="1">OKT4</td><td align="left" valign="top" rowspan="1" colspan="1">Helper T cell</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD8</td><td align="left" valign="top" rowspan="1" colspan="1">BUV496</td><td align="left" valign="top" rowspan="1" colspan="1">SK1</td><td align="left" valign="top" rowspan="1" colspan="1">Cytotoxic T cell</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD94</td><td align="left" valign="top" rowspan="1" colspan="1">AF700</td><td align="left" valign="top" rowspan="1" colspan="1">KLRD1</td><td align="left" valign="top" rowspan="1" colspan="1">Subset: Functional marker of T cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD69</td><td align="left" valign="top" rowspan="1" colspan="1">BB700</td><td align="left" valign="top" rowspan="1" colspan="1">FN50</td><td align="left" valign="top" rowspan="1" colspan="1">TRM subset</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD103</td><td align="left" valign="top" rowspan="1" colspan="1">PEVio615</td><td align="left" valign="top" rowspan="1" colspan="1">REA803</td><td align="left" valign="top" rowspan="1" colspan="1">TRM subset</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD127</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;CY7</td><td align="left" valign="top" rowspan="1" colspan="1">R34.34</td><td align="left" valign="top" rowspan="1" colspan="1">TRM; tissue homeostasis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PD&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">BV711</td><td align="left" valign="top" rowspan="1" colspan="1">EH12.1</td><td align="left" valign="top" rowspan="1" colspan="1">TRM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR7</td><td align="left" valign="top" rowspan="1" colspan="1">BV421</td><td align="left" valign="top" rowspan="1" colspan="1">2&#8208;L1&#8208;A</td><td align="left" valign="top" rowspan="1" colspan="1">Na&#239;ve; TCM; Lymph homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD27</td><td align="left" valign="top" rowspan="1" colspan="1">BV786</td><td align="left" valign="top" rowspan="1" colspan="1">L128</td><td align="left" valign="top" rowspan="1" colspan="1">Memory: TCM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD28</td><td align="left" valign="top" rowspan="1" colspan="1">BUV395</td><td align="left" valign="top" rowspan="1" colspan="1">CD28.2</td><td align="left" valign="top" rowspan="1" colspan="1">Memory: differentiation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD161</td><td align="left" valign="top" rowspan="1" colspan="1">BUV615</td><td align="left" valign="top" rowspan="1" colspan="1">HP3G10</td><td align="left" valign="top" rowspan="1" colspan="1">CD4: Th17; CD8: cytotoxicity</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR6</td><td align="left" valign="top" rowspan="1" colspan="1">BV650</td><td align="left" valign="top" rowspan="1" colspan="1">11A9</td><td align="left" valign="top" rowspan="1" colspan="1">Subset: Th17; Tissue homing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR10</td><td align="left" valign="top" rowspan="1" colspan="1">APC</td><td align="left" valign="top" rowspan="1" colspan="1">1B5</td><td align="left" valign="top" rowspan="1" colspan="1">Subset: Th22</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD39</td><td align="left" valign="top" rowspan="1" colspan="1">BV480</td><td align="left" valign="top" rowspan="1" colspan="1">TU66</td><td align="left" valign="top" rowspan="1" colspan="1">Immunoregulation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TIGIT</td><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">A15153G</td><td align="left" valign="top" rowspan="1" colspan="1">Immunoregulation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCR5</td><td align="left" valign="top" rowspan="1" colspan="1">VioB515</td><td align="left" valign="top" rowspan="1" colspan="1">REA245</td><td align="left" valign="top" rowspan="1" colspan="1">Tissue homeostasis; HIV entry</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HLA&#8208;DQ</td><td align="left" valign="top" rowspan="1" colspan="1">BUV563</td><td align="left" valign="top" rowspan="1" colspan="1">TU169</td><td align="left" valign="top" rowspan="1" colspan="1">Late Activation; Differentially expressed in RNA&#8208;seq</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD38</td><td align="left" valign="top" rowspan="1" colspan="1">APC&#8208;Fire810</td><td align="left" valign="top" rowspan="1" colspan="1">HIT2</td><td align="left" valign="top" rowspan="1" colspan="1">Early Activation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD154</td><td align="left" valign="top" rowspan="1" colspan="1">BUV737</td><td align="left" valign="top" rowspan="1" colspan="1">TRAP1</td><td align="left" valign="top" rowspan="1" colspan="1">Early Activation</td></tr></tbody></table></table-wrap></sec><sec id="cytoa24782-sec-0002"><label>2</label><title>Similarities to other <styled-content style="fixed-case" toggle="no">OMIPs</styled-content>
</title><p>Many OMIPs have focused on phenotyping human T cell subsets and activation, though all are in the context of blood&#8208;derived lymphocytes. Particularly, OMIP&#8208;071 extensively covers both the memory and effector T cell subsets of both CD4<sup>+</sup> and CD8<sup>+</sup> T cells. However, they primarily use chemokine receptors for the identification of effector subsets. In tissue, using chemokine receptors to identify helper T cell subsets are somewhat confounded, as they are more often described as markers for homing to specific tissues; CCR6 to gut, CXCR6 to lung, and so forth. Further, the use of chemokine receptors in tissues would require careful curation, as they are particularly prone to enzymatic cleavage. OMIP&#8208;082 and &#8208;070 have designed panels for use in enzymatically liberated human tissue cells; the panel presented in OMIP&#8208;070 was designed for the identification of NK cells, whereby CD56 was consistently cleaved and fortunately resolved by using an alternative target, NKp46; they did not test alternative enzyme products, as was performed in OMIP&#8208;82 and in this OMIP. The panel design in OMIP&#8208;82 is focused on identifying innate lymphoid cells, NK cells, MAIT cells, and gamma&#8208;delta T cells in gastrointestinal tissues, which does not require dispase digestion to investigate cells in epidermal and dermal tissues. Currently, there is no OMIP that optimizes the combination of enzyme&#8208;digestion combined with antibody&#8208;clone selection to identify TRMs from both the epidermis and dermis of human tissues.</p></sec><sec id="cytoa24782-sec-0006"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Kirstie Melissa Bertram:</bold> Investigation; conceptualization; writing &#8211; review and editing; methodology; validation; formal analysis; visualization; supervision; data curation. <bold>Thomas O&#8217;Neil R:</bold> Conceptualization; investigation; methodology; validation; visualization; writing &#8211; review and editing; formal analysis; data curation; writing &#8211; original draft. <bold>Andrew N Harman:</bold> Writing &#8211; review and editing; supervision; funding acquisition; resources; project administration. <bold>Anthony L. Cunningham:</bold> Funding acquisition; writing &#8211; review and editing; supervision; resources; project administration. <bold>Najla Nasr:</bold> Funding acquisition; writing &#8211; review and editing; supervision; resources; project administration; conceptualization.</p></sec><sec id="cytoa24782-sec-0004"><title>FUNDING INFORMATION</title><p>This work was supported by the Neil and Norma Hill Foundation, the Westmead Medical Research Foundation, and the Australian National Health and Medical Research Council (NHMRC ideas grant #APP1181482).</p></sec><sec sec-type="COI-statement" id="cytoa24782-sec-0005"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cytoa24782-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Data S1.</bold> Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-851-s002.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="cytoa24782-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Data S2.</bold> Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-851-s003.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="cytoa24782-supitem-0003" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>MIFlowCyt</bold> MIFlowCyt item checklist.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-103-851-s001.doc" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="cytoa24782-sec-0003"><title>ACKNOWLEDGMENTS</title><p>Flow Cytometry was performed at the Westmead Scientific Platforms, which are supported by the Westmead Research Hub, the Westmead Institute for Medical Research, the Cancer Institute New South Wales, the National Health and Medical Research Council, and the Ian Potter Foundation. Open access publishing facilitated by The University of Sydney, as part of the Wiley &#8208; The University of Sydney agreement via the Council of Australian University Librarians.</p></ack><ref-list id="cytoa24782-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="cytoa24782-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0001"><string-name name-style="western"><surname>O'Neil</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Truong</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Arshad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shacklett</surname><given-names>BL</given-names></string-name>, <string-name name-style="western"><surname>Cunningham</surname><given-names>AL</given-names></string-name>, et al. <article-title>The role of tissue resident memory CD4 T cells in herpes simplex viral and HIV infection</article-title>. <source>Viruses</source>. <year>2021</year>;<volume>13</volume>(<issue>3</issue>):<fpage>359</fpage>.<pub-id pub-id-type="pmid">33668777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v13030359</pub-id><pub-id pub-id-type="pmcid">PMC7996247</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0002"><string-name name-style="western"><surname>Gebhardt</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Wakim</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Eidsmo</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Reading</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Heath</surname><given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Carbone</surname><given-names>FR</given-names></string-name>. <article-title>Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus</article-title>. <source>Nat Immunol</source>. <year>2009</year>;<volume>10</volume>(<issue>5</issue>):<fpage>524</fpage>&#8211;<lpage>530</lpage>.<pub-id pub-id-type="pmid">19305395</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.1718</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0003"><string-name name-style="western"><surname>Shacklett</surname><given-names>BL</given-names></string-name>, <string-name name-style="western"><surname>Ferre</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Kiniry</surname><given-names>BE</given-names></string-name>. <article-title>Defining T cell tissue residency in humans: implications for HIV pathogenesis and vaccine design</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2020</year>;<volume>17</volume>(<issue>2</issue>):<fpage>109</fpage>&#8211;<lpage>117</lpage>.<pub-id pub-id-type="pmid">32052270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11904-020-00481-7</pub-id><pub-id pub-id-type="pmcid">PMC7072053</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0004"><string-name name-style="western"><surname>Chege</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sheth</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Kain</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Kovacs</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Loutfy</surname><given-names>M</given-names></string-name>, et al. <article-title>Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long&#8208;term antiretroviral therapy</article-title>. <source>AIDS</source>. <year>2011</year>;<volume>25</volume>(<issue>6</issue>):<fpage>741</fpage>&#8211;<lpage>749</lpage>.<pub-id pub-id-type="pmid">21378536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0b013e328344cefb</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0005"><string-name name-style="western"><surname>Cantero&#8208;P&#233;rez</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Grau&#8208;Exp&#243;sito</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Serra&#8208;Peinado</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rosero</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Luque&#8208;Ballesteros</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Astorga&#8208;Gamaza</surname><given-names>A</given-names></string-name>, et al. <article-title>Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa</article-title>. <source>Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>4739</fpage>.<pub-id pub-id-type="pmid">31628331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-12732-2</pub-id><pub-id pub-id-type="pmcid">PMC6802119</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0006"><string-name name-style="western"><surname>Botting</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Bertram</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Baharlou</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sandgren</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Fletcher</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rhodes</surname><given-names>JW</given-names></string-name>, et al. <article-title>Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes</article-title>. <source>J Leukoc Biol</source>. <year>2017</year>;<volume>101</volume>(<issue>6</issue>):<fpage>1393</fpage>&#8211;<lpage>1403</lpage>.<pub-id pub-id-type="pmid">28270408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1189/jlb.4A1116-496R</pub-id><pub-id pub-id-type="pmcid">PMC5433859</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0007"><string-name name-style="western"><surname>Wong</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Ong</surname><given-names>DEH</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>FSH</given-names></string-name>, <string-name name-style="western"><surname>Teng</surname><given-names>KWW</given-names></string-name>, <string-name name-style="western"><surname>McGovern</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Narayanan</surname><given-names>S</given-names></string-name>, et al. <article-title>A high&#8208;dimensional atlas of human T cell diversity reveals tissue&#8208;specific trafficking and cytokine signatures</article-title>. <source>Immunity</source>. <year>2016</year>;<volume>45</volume>(<issue>2</issue>):<fpage>442</fpage>&#8211;<lpage>456</lpage>.<pub-id pub-id-type="pmid">27521270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2016.07.007</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0008"><string-name name-style="western"><surname>Autengruber</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gereke</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hansen</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Hennig</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bruder</surname><given-names>D</given-names></string-name>. <article-title>Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function</article-title>. <source>Eur J Microbiol Immunol (Bp)</source>. <year>2012</year>;<volume>2</volume>(<issue>2</issue>):<fpage>112</fpage>&#8211;<lpage>120</lpage>.<pub-id pub-id-type="pmid">24672679</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1556/EuJMI.2.2012.2.3</pub-id><pub-id pub-id-type="pmcid">PMC3956959</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0009"><string-name name-style="western"><surname>Doyle</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Vine</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Bertram</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Baharlou</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Rhodes</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Dervish</surname><given-names>S</given-names></string-name>, et al. <article-title>Optimal isolation protocols for examining and interrogating mononuclear phagocytes from human intestinal tissue</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>727952</elocation-id>.<pub-id pub-id-type="pmid">34566985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.727952</pub-id><pub-id pub-id-type="pmcid">PMC8462295</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0010"><string-name name-style="western"><surname>Doyle</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Fewings</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Ctercteko</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Byrne</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Harman</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Bertram</surname><given-names>KM</given-names></string-name>. <article-title>OMIP 082: a 25&#8208;color phenotyping to define human innate lymphoid cells, natural killer cells, mucosal&#8208;associated invariant T cells, and &#947;&#948; T cells from freshly isolated human intestinal tissue</article-title>. <source>Cytometry A</source>. <year>2022</year>;<volume>101</volume>(<issue>3</issue>):<fpage>196</fpage>&#8211;<lpage>202</lpage>.<pub-id pub-id-type="pmid">35018731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.24529</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0011"><string-name name-style="western"><surname>Kumar</surname><given-names>BV</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Miron</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Granot</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Guyer</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Carpenter</surname><given-names>DJ</given-names></string-name>, et al. <article-title>Human tissue&#8208;resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>20</volume>(<issue>12</issue>):<fpage>2921</fpage>&#8211;<lpage>2934</lpage>.<pub-id pub-id-type="pmid">28930685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2017.08.078</pub-id><pub-id pub-id-type="pmcid">PMC5646692</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0012"><string-name name-style="western"><surname>Reilly Emma</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Emo</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Buckley</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Reilly</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Chaves</surname><given-names>FA</given-names></string-name>, et al. <article-title>TRM integrins CD103 and CD49a differentially support adherence and motility after resolution of influenza virus infection</article-title>. <source>Proc Natl Acad Sci</source>. <year>2020</year>;<volume>117</volume>(<issue>22</issue>):<fpage>12306</fpage>&#8211;<lpage>12314</lpage>.<pub-id pub-id-type="pmid">32439709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1915681117</pub-id><pub-id pub-id-type="pmcid">PMC7275699</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0013"><string-name name-style="western"><surname>Watanabe</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Gehad</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Scott</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Teague</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Schlapbach</surname><given-names>C</given-names></string-name>, et al. <article-title>Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells</article-title>. <source>Sci Transl Med</source>. <year>2015</year>;<volume>7</volume>(<issue>279</issue>):<elocation-id>279ra39</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.3010302</pub-id><pub-id pub-id-type="pmcid">PMC4425193</pub-id><pub-id pub-id-type="pmid">25787765</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0014"><string-name name-style="western"><surname>Klicznik</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Morawski</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>H&#246;llbacher</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Varkhande</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Motley</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Kuri&#8208;Cervantes</surname><given-names>L</given-names></string-name>, et al. <article-title>Human CD4(+)CD103(+) cutaneous resident memory T cells are found in the circulation of healthy individuals</article-title>. <source>Sci Immunol</source>. <year>2019</year>;<volume>4</volume>(<issue>37</issue>):<elocation-id>eaav8995</elocation-id>.<pub-id pub-id-type="pmid">31278120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aav8995</pub-id><pub-id pub-id-type="pmcid">PMC7057121</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0015"><string-name name-style="western"><surname>Woodward Davis</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Roozen</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Dufort</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>DeBerg</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Delaney</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Mair</surname><given-names>F</given-names></string-name>, et al. <article-title>The human tissue&#8208;resident CCR5(+) T cell compartment maintains protective and functional properties during inflammation</article-title>. <source>Sci Transl Med</source>. <year>2019</year>;<volume>11</volume>(<issue>521</issue>):<elocation-id>eaaw8718</elocation-id>.<pub-id pub-id-type="pmid">31801887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aaw8718</pub-id><pub-id pub-id-type="pmcid">PMC7416666</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0016"><string-name name-style="western"><surname>Thome</surname><given-names>JJC</given-names></string-name>, <string-name name-style="western"><surname>Yudanin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ohmura</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kubota</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Grinshpun</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sathaliyawala</surname><given-names>T</given-names></string-name>, et al. <article-title>Spatial map of human T cell compartmentalization and maintenance over decades of life</article-title>. <source>Cell</source>. <year>2014</year>;<volume>159</volume>(<issue>4</issue>):<fpage>814</fpage>&#8211;<lpage>828</lpage>.<pub-id pub-id-type="pmid">25417158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.10.026</pub-id><pub-id pub-id-type="pmcid">PMC4243051</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0017"><string-name name-style="western"><surname>Fonseca</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Beura</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Quarnstrom</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Ghoneim</surname><given-names>HE</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zebley</surname><given-names>CC</given-names></string-name>, et al. <article-title>Developmental plasticity allows outside&#8208;in immune responses by resident memory T cells</article-title>. <source>Nat Immunol</source>. <year>2020</year>;<volume>21</volume>(<issue>4</issue>):<fpage>412</fpage>&#8211;<lpage>421</lpage>.<pub-id pub-id-type="pmid">32066954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-020-0607-7</pub-id><pub-id pub-id-type="pmcid">PMC7096285</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0018"><string-name name-style="western"><surname>Gupta</surname><given-names>PK</given-names></string-name>, <string-name name-style="western"><surname>Godec</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wolski</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Adland</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Yates</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pauken</surname><given-names>KE</given-names></string-name>, et al. <article-title>CD39 expression identifies terminally exhausted CD8+ T cells</article-title>. <source>PLoS Pathog</source>. <year>2015</year>;<volume>11</volume>(<issue>10</issue>):<elocation-id>e1005177</elocation-id>.<pub-id pub-id-type="pmid">26485519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1005177</pub-id><pub-id pub-id-type="pmcid">PMC4618999</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0019"><string-name name-style="western"><surname>Tan</surname><given-names>DBA</given-names></string-name>, <string-name name-style="western"><surname>Ong</surname><given-names>NE</given-names></string-name>, <string-name name-style="western"><surname>Zimmermann</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Price</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Moodley</surname><given-names>YP</given-names></string-name>. <article-title>An evaluation of CD39 as a novel immunoregulatory mechanism invoked by COPD</article-title>. <source>Hum Immunol</source>. <year>2016</year>;<volume>77</volume>(<issue>10</issue>):<fpage>916</fpage>&#8211;<lpage>920</lpage>.<pub-id pub-id-type="pmid">27430193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.humimm.2016.07.007</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0020"><string-name name-style="western"><surname>Losurdo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Scirgolea</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Alvisi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Errico</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>di Tommaso</surname><given-names>L</given-names></string-name>, et al. <article-title>Single&#8208;cell profiling defines the prognostic benefit of CD39 high tissue resident memory CD8+ T cells in luminal&#8208;like breast cancer</article-title>. <source>Commun Biol</source>. <year>2021</year>;<volume>4</volume>(<issue>1</issue>):<fpage>1117</fpage>.<pub-id pub-id-type="pmid">34552178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-021-02595-z</pub-id><pub-id pub-id-type="pmcid">PMC8458450</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0021"><string-name name-style="western"><surname>Gu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ni</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>J</given-names></string-name>, et al. <article-title>Human CD39(hi) regulatory T cells present stronger stability and function under inflammatory conditions</article-title>. <source>Cell Mol Immunol</source>. <year>2017</year>;<volume>14</volume>(<issue>6</issue>):<fpage>521</fpage>&#8211;<lpage>528</lpage>.<pub-id pub-id-type="pmid">27374793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cmi.2016.30</pub-id><pub-id pub-id-type="pmcid">PMC5518817</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0022"><string-name name-style="western"><surname>Ge</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Peppelenbosch</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Sprengers</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kwekkeboom</surname><given-names>J</given-names></string-name>. <article-title>TIGIT, the next step towards successful combination immune checkpoint therapy in cancer</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>699895</elocation-id>.<pub-id pub-id-type="pmid">34367161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.699895</pub-id><pub-id pub-id-type="pmcid">PMC8339559</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0023"><string-name name-style="western"><surname>Jaeger</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Gamini</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Cella</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Schettini</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Bugatti</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>S</given-names></string-name>, et al. <article-title>Single&#8208;cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions</article-title>. <source>Nat Commun</source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1921</fpage>.<pub-id pub-id-type="pmid">33771991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-22164-6</pub-id><pub-id pub-id-type="pmcid">PMC7997960</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0024"><string-name name-style="western"><surname>Konduri</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Oyewole&#8208;Said</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Vazquez&#8208;Perez</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Weldon</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Halpert</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Levitt</surname><given-names>JM</given-names></string-name>, et al. <article-title>CD8+CD161+ T&#8208;cells: cytotoxic memory cells with high therapeutic potential</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>11</volume>:<elocation-id>613204</elocation-id>.<pub-id pub-id-type="pmid">33597948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.613204</pub-id><pub-id pub-id-type="pmcid">PMC7882609</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0025"><string-name name-style="western"><surname>Braud</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Aldemir</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Breart</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ferlin</surname><given-names>WG</given-names></string-name>. <article-title>Expression of CD94&#8208;NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells</article-title>. <source>Trends Immunol</source>. <year>2003</year>;<volume>24</volume>(<issue>4</issue>):<fpage>162</fpage>&#8211;<lpage>164</lpage>.<pub-id pub-id-type="pmid">12697440</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1471-4906(03)00064-4</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0026"><string-name name-style="western"><surname>Eug&#232;ne</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jouand</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ducoin</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Dansette</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Oger</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Deleine</surname><given-names>C</given-names></string-name>, et al. <article-title>The inhibitory receptor CD94/NKG2A on CD8+ tumor&#8208;infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/&#946;2m overexpression</article-title>. <source>Mod Pathol</source>. <year>2020</year>;<volume>33</volume>(<issue>3</issue>):<fpage>468</fpage>&#8211;<lpage>482</lpage>.<pub-id pub-id-type="pmid">31409873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41379-019-0322-9</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0027"><string-name name-style="western"><surname>Boland</surname><given-names>BS</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Omilusik</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Duong</surname><given-names>HG</given-names></string-name>, et al. <article-title>Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single&#8208;cell analyses</article-title>. <source>Sci Immunol</source>. <year>2020</year>;<volume>5</volume>(<issue>50</issue>):<elocation-id>eaab4432</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.abb4432</pub-id><pub-id pub-id-type="pmcid">PMC7733868</pub-id><pub-id pub-id-type="pmid">32826341</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0028"><string-name name-style="western"><surname>Elmentaite</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname><given-names>ADB</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>James</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Ortmann</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gomes</surname><given-names>T</given-names></string-name>, et al. <article-title>Single&#8208;cell sequencing of developing human gut reveals transcriptional links to childhood Crohn's disease</article-title>. <source>Dev Cell</source>. <year>2020</year>;<volume>55</volume>(<issue>6</issue>):<fpage>771</fpage>&#8211;<lpage>783.e5</lpage>.<pub-id pub-id-type="pmid">33290721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.devcel.2020.11.010</pub-id><pub-id pub-id-type="pmcid">PMC7762816</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0029"><string-name name-style="western"><surname>Martin</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Boschetti</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Ungaro</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Giri</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Grout</surname><given-names>JA</given-names></string-name>, et al. <article-title>Single&#8208;cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti&#8208;TNF therapy</article-title>. <source>Cell</source>. <year>2019</year>;<volume>178</volume>(<issue>6</issue>):<fpage>1493</fpage>&#8211;<lpage>1508.e20</lpage>.<pub-id pub-id-type="pmid">31474370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2019.08.008</pub-id><pub-id pub-id-type="pmcid">PMC7060942</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0030"><string-name name-style="western"><surname>Sia</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Bizzell</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Madan&#8208;Lala</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rengarajan</surname><given-names>J</given-names></string-name>. <article-title>Engaging the CD40&#8208;CD40L pathway augments T&#8208;helper cell responses and improves control of <italic toggle="yes">Mycobacterium tuberculosis</italic> infection</article-title>. <source>PLoS Pathog</source>. <year>2017</year>;<volume>13</volume>(<issue>8</issue>):<elocation-id>e1006530</elocation-id>.<pub-id pub-id-type="pmid">28767735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1006530</pub-id><pub-id pub-id-type="pmcid">PMC5540402</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0031"><string-name name-style="western"><surname>Sandoval&#8208;Montes</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Santos&#8208;Argumedo</surname><given-names>L</given-names></string-name>. <article-title>CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines</article-title>. <source>J Leukoc Biol</source>. <year>2005</year>;<volume>77</volume>(<issue>4</issue>):<fpage>513</fpage>&#8211;<lpage>521</lpage>.<pub-id pub-id-type="pmid">15618297</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1189/jlb.0404262</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0032"><string-name name-style="western"><surname>Sozzani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Vermi</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>del Prete</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Facchetti</surname><given-names>F</given-names></string-name>. <article-title>Trafficking properties of plasmacytoid dendritic cells in health and disease</article-title>. <source>Trends Immunol</source>. <year>2010</year>;<volume>31</volume>(<issue>7</issue>):<fpage>270</fpage>&#8211;<lpage>277</lpage>.<pub-id pub-id-type="pmid">20579936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2010.05.004</pub-id></mixed-citation></ref><ref id="cytoa24782-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cytoa24782-cit-0033"><string-name name-style="western"><surname>Shang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Duan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Perkey</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Wietgrefe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zupancic</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>AJ</given-names></string-name>, et al. <article-title>Epithelium&#8208;innate immune cell axis in mucosal responses to SIV</article-title>. <source>Mucosal Immunol</source>. <year>2017</year>;<volume>10</volume>(<issue>2</issue>):<fpage>508</fpage>&#8211;<lpage>519</lpage>.<pub-id pub-id-type="pmid">27435105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mi.2016.62</pub-id><pub-id pub-id-type="pmcid">PMC5250613</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>